Aberrant signalling of PI3K/AKT has been illustrated to be present within the majority of NSCLC tumours,74, 75 with several reports having implicated this pathway in the onset and progression of this cancer type.76 The gene discussed is AKT1; the disease is non-small cell lung carcinoma.